|
Mr. Martin Gerstel, Chairman
Martin Gerstel is Chairman of Compugen Ltd., a publicly owned drug and diagnostic discovery company, of Keddem Bioscience, a privately owned drug discovery company and Co-Chairman of Itamar Medical, a publicly owned medical device company, all of which are headquartered in Israel. Prior to relocating to Israel in 1994, Mr. Gerstel was the Co-Chairman and CEO of ALZA Corporation, a pharmaceutical company based on advanced drug delivery.
In addition, Mr. Gerstel currently serves as a director of YEDA Technology Transfer, Yissum Technologies and the Foundation for the US National Medals of Science and Technology. He is a member of the Board of Governors and the Executive Committee of the Weizmann Institute of Science and the Board of Governors of the Hebrew University of Jerusalem, and is an advisor to the Burrill Life Science Funds and to the Board of the Israel-U.S. BiNational Industrial Research and Development (“BIRD”) Foundation.
Mr. Gerstel is a graduate of Yale University and the Stanford Graduate School of Business.
Dr. Michael Anghel
Dr. Michael Anghel serves as a member of various boards of major Israeli corporations, including Partner Ltd., Syneron Medical Ltd., ECI Telecom Ltd., Scopus Ltd. Previously, Dr. Anghel served on the management of the Discount Investment Corporation and as CEO of Discount Capital Markets, the investment banking arm of the Israel Discount Bank. He was actively involved in the founding and management of various technology and communications enterprises including Cellcom and Tevel. Dr. Anghel holds a B.A. (Economics) from the Hebrew University in Jerusalem and an M.B.A. and Ph.D. from Columbia University in New York.
Dr. Rafi Hofstein
Dr. Rafi Hofstein is President and CEO of Hadasit Ltd., the Technology Holdings Company of Hadassah Medical Organization. Previously, he served as the President of Mindsense Biosystems Ltd. and as Business Unit Director of Ecogen Inc. in Langhorne PA, after serving as the Scientific Director of its Israel office. Dr. Hofstein received his PhD and Master of Science in life-sciences and chemistry from the Weizmann Institute of Science, and completed postdoctoral training at the Harvard Medical School in Boston, MA, in the departments of biological chemistry and neurobiology.
Dr. Adina Makover
Dr. Adina Makover currently serves as Director of Life Sciences Investments at Proseed VC and is a consultant to private investors. For the past four years, Dr. Makover has been the managing director of Tzina Bio Perspective, a private investment company focusing on biotechnology and medical device ventures. Previously, she held senior management positions in biotech and device companies focusing on drugs, diagnostics and tissue engineering. Holding positions of CEO and board member, R&D, process development and production manager, Dr. Makover was responsible for both the technology and business aspects.
Dr. Makover holds a joint PhD degree in life sciences from Columbia University (USA) and Weizmann Institute of Science (Israel) and performed post-doctoral research at the Weizmann Institute of Science. Dr. Makover also holds an MBA degree from Bar-Ilan University.
Mr. Leon Recanati
Mr. Leon Recanati is the founder and CEO of GlenRock Israel, a private equity group. Mr. Recanati was Chairman and CEO of IDB Holding Corporation, one of the largest investment groups in Israel until May 2003. In addition, he served as Chairman of Clal Industries and Investments, Discount Investment Corporation, and Azorim Investment Development and Construction. Mr. Recanati was Chairman of Delek Israel Fuel Corporation and Super-Sol until 1997, in addition to several other positions in a variety of operating companies in Israel.
Mr. Recanati's personal involvement in organizations and diverse causes has earned him a reputation as one of Israel's outstanding community leaders. He is Chairman of the Board of the Israel National Museum of Science in Haifa, Vice Chairman of the Israel Cancer Association and Chairman of Tel-Aviv University's Development Committee. He is also an active member of the Board of Governors of Tel-Aviv University and the Hebrew University of Jerusalem, The Technion Israel Institute of Technology, The Jewish Agency, and Chairman of Tapuah - The Israeli Society for the Advancement of the Information Age.
Mr. Recanati received his BA and MBA degrees from The Hebrew University of Jerusalem and Honorary Doctorates from the Technion Israel Institute of Technology and Tel-Aviv University.
Mr Steven B. Ruchefsky
Mr. Steven B. Ruchefsky has been working since 2001 with the founder and chief executive officer of a prominent multi-strategy hedge fund, and is responsible for a broad portfolio of private equity, venture capital and real estate investments. In addition, he currently serves as a board member of several United States and international public and private companies. In 2000, Mr. Ruchefsky established a private investment company for one of his clients, and was responsible for the development and implementation of an investment strategy and for the establishment of financial controls and operating procedures. In addition, Mr. Ruchefsky was a principal of an early stage/seed venture capital firm he helped establish and sat on the boards of several of its portfolio companies. Prior to 2000, Mr. Ruchefsky practiced law in New York City for fifteen years, and was a partner of a prestigious New York City law firm, chair of its specialized litigation department and member of the firm’s management group.
Mr. Ruchefsky is a graduate of The George Washington University Law School.
Dr. Simcha Sadan
Dr. Simcha Sadan has been a faculty member at the Business School of Tel-Aviv University since 1976. He served as the chairman of the Tel-Aviv University Accounting Department (1977-1980) and as an Assistant Professor at New York University (1972-1975). He is a management and business consultant for various companies and an academic consultant for professional courses. Dr. Sadan has held positions of General Manager and Chief Executive Officer of companies, has been a member of Boards of Directors and a member of governmental & professional committees.
Dr. Sadan holds a PhD in Business Administration from the University of California, Berkeley (1972); an MBA in Accounting and Finance (1967) and a BA in Economics and Statistics (1966), both from the Hebrew University in Jerusalem.
Dr. Sadan also holds a Bachelor of Laws (LLB) degree from Tel-Aviv University (2002).
Dr. Eli Zangvil
Dr. Zangvil currently serves as Vice President, Business Development at Compugen. Prior to Compugen, he served as Chief Operating Officer of UltraShape. Previously, Dr. Zangvil was Head of Medical Services of the Israeli Defense Force's Central Command, where he held the rank of Colonel. Prior to this, he held the position of Assistant Director of the Rambam Medical Center in Haifa, Israel.
Dr. Zangvil holds an M.D. from the Hebrew University of Jerusalem, and specializes in internal medicine. He has a Master's Degree in Health Administration from Tel-Aviv University, Israel.
Professor Ilan Chet, Special Advisor to the Board of Directors
Ex-President of the Weizmann Institute
Prof. Chet was President of the Weizmann Institute of Science (2001-2006), VP R&D of the Hebrew Univ. of Jerusalem (1992-2001); Dean of the Faculty of Agriculture in the Hebrew Univ. of Jerusalem (1986-89); Director of the Otto Warburg Center of Biotechnology in Agriculture (1983-86); Head of the Dept. of Plant Pathology and Microbiology, Faculty of Agriculture, Hebrew Univ. of Jerusalem (1981-83) ; Professor of Microbiology (1978); Assoc. Professor of Microbiology (1975); Sr. Lecturer in Microbiology (1972). He was visiting Professor at numerous Universities including Harvard, Cornell, Rutgers, Auburn, Gottingen, Lund, Cape Town (1975-2006). Prof. Chet has published more than 360 publications and filed 32 patents. He instructed more than 80 M.Sc. and 30 Ph.D. students.
Professor Chet received the Israel Prize (1994) and the Wolf prize (1998) for research, he was a Member of The Advisory Panel of NATO Science Program (2000), a member of the External Advisory Group (EAG) to the European Union Research (1998), Chairman of the Rothschild Prize Committee, invited speaker at the world Economic Forum in Davos.
Professor Chet holds a PhD, an M.Sc. (Hons) and a B.Sc. (Hons) from the Faculty of Agriculture of the Hebrew University of Jerusalem.
|
 |
Learn more about us:
Company
Profile
Management
Team
Scientific
Advisors
|
